IPO subscription report
Symbiotec Pharmalab Limited IPO — category-wise subscription
Final bidding figures by investor category with an arithmetic estimate of allotment odds. Share the card on WhatsApp or download it as an image.
VIA Capital • IPO subscription report
Symbiotec Pharmalab Limited
SYMBIOTEC • Mainboard • Latest captured figures
Issue dates
24 Aug 2026 – 27 Aug 2026
Price band
Rs.938 to Rs.988
Lot size
—
Total subscription
3.67x
Category-wise bidding
| Category | Times subscribed | Applications |
|---|---|---|
QIB Qualified Institutional Buyers — mutual funds, insurers, banks and FPIs. | 0.59x | — |
NII (Total) All non-institutional / HNI bids above ₹2 lakh. | 12.18x | — |
Retail (RII) Individual investors applying up to ₹2 lakh. | 5.05x | — |
Employees Shares reserved for eligible employees of the company. | 5.85x | — |
| Total | 3.67x | — |
Total issue size
₹1,757 Cr
Shares offered
1.31 Cr shares
Shares bid for
—
Bids received (value)
—
Day-wise subscription
| Day | QIB | NII | Retail | Total | Applications |
|---|---|---|---|---|---|
Day 1 24 Aug 2026 | 0.35x | 1.04x | 0.95x | 0.62x | — |
Day 2 25 Aug 2026 | 0.54x | 2.99x | 2.10x | 1.34x | — |
Day 4 27 Aug 2026 | 0.59x | 12.18x | 5.05x | 3.67x | — |
Captured from the exchange feed once per bidding day. Days before this report was first captured are not available.
Estimated allotment chance
Retail (1 lot)
Approx. 1 in 5
1 lot • lottery basis
sNII (₹2–10 lakh)
Approx. 1 in 12
1 lot • lottery basis
bNII (Above ₹10 lakh)
Approx. 1 in 12
1 lot • proportionate basis
Educational information only. Subscription figures are sourced from exchange public data and allotment chances are arithmetic estimates from those figures — the binding allotment is the Basis of Allotment published by the registrar. VIA Capital does not provide investment advice or allotment guarantees. Read the RHP before investing. Source: NSE public market data. Captured 27/8/2026, 1:36:29 am.
Educational content only. VIA Capital does not provide buy/sell calls, tips, or personalized advice. Always do your own research.